白内障・白内障手術ならサトウ眼科クリニックへ

1. Oshitari T, Polewski P, Chadda M, Li AF, Sato T, Roy S.　

Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability. Diabetes. 2006 Jan;55(1):86-92.

2. Li AF, Sato T, Haimovici R, Okamoto T, Roy S. 　

High glucose alters connexin 43 expression and gap junction intercellular communication activity in retinal pericytes. Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5376-82.

3. Roy S, Sato T, Paryani G, Kao R. 　

Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes. 2003 May;52(5):1229-34.

4. Sato T, Haimovici R, Kao R, Li AF, Roy S. 　

Downregulation of connexin 43 expression by high glucose reduces gap junction activity in microvascular endothelial cells. Diabetes. 2002 May;51(5):1565-71.

5. Sato T, Roy S.　

Effect of high glucose on fibronectin expression and cell proliferation in trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2002 Jan;43(1):170-5.

6. Sato T, Paryani G, Kao RS, Li AF, Roy S.

Antisense oligonucleotides modulate high glucose-induced laminin overexpression and cell proliferation: a potential for therapeutic application in diabeticmicroangiopathy.
Antisense Nucleic Acid Drug Dev. 2001 Dec;11(6):387-94.

7. Sato T, Muto T, Ishibashi Y, Roy S.

Short-term effect of beta-adrenoreceptor blocking agents on ocular blood flow. Curr Eye Res. 2001 Oct;23(4):298-306.

8. Roy S, Sato T.　

Role of vascular basement membrane components in diabetic microangiopathy. Drug News Perspect. 2000 Mar;13(2):91-8.